| Molecular dynamics simulations of imidazolium-based ionic liquid/water mixtures: Alkyl side chain length and anion effects S Feng, GA Voth Fluid phase equilibria 294 (1-2), 148-156, 2010 | 226 | 2010 |
| Prediction of protein–ligand binding poses via a combination of induced fit docking and metadynamics simulations AJ Clark, P Tiwary, K Borrelli, S Feng, EB Miller, R Abel, RA Friesner, ... Journal of chemical theory and computation 12 (6), 2990-2998, 2016 | 222 | 2016 |
| Proton solvation and transport in hydrated nafion S Feng, GA Voth The Journal of Physical Chemistry B 115 (19), 5903-5912, 2011 | 161 | 2011 |
| Transferable coarse-grained models for ionic liquids Y Wang, S Feng, GA Voth Journal of chemical theory and computation 5 (4), 1091-1098, 2009 | 94 | 2009 |
| Effects of polymer morphology on proton solvation and transport in proton-exchange membranes S Feng, J Savage, GA Voth The Journal of Physical Chemistry C 116 (36), 19104-19116, 2012 | 58 | 2012 |
| Quantum instanton evaluation of the thermal rate constants and kinetic isotope effects for SiH4+ H→ SiH3+ H2 reaction in full Cartesian space W Wang, S Feng, Y Zhao The Journal of chemical physics 126 (11), 2007 | 22 | 2007 |
| Discovery of a potent and selective tyrosine kinase 2 inhibitor: TAK-279 S Leit, J Greenwood, S Carriero, S Mondal, R Abel, M Ashwell, ... Journal of Medicinal Chemistry 66 (15), 10473-10496, 2023 | 12 | 2023 |
| FEP Protocol Builder: Optimization of Free Energy Perturbation Protocols Using Active Learning C de Oliveira, K Leswing, S Feng, R Kanters, R Abel, S Bhat Journal of Chemical Information and Modeling 63 (17), 5592-5603, 2023 | 4 | 2023 |
| Identification of potent paracaspase MALT1 inhibitors for hematological malignancies W Yin, N Zhe, A Placzek, M Trzoss, G Krilov, S Feng, M Lawrenz, ... Blood 136, 30, 2020 | 3 | 2020 |
| Correction to “Proton Solvation and Transport in Hydrated Nafion” S Feng, GA Voth The Journal of Physical Chemistry B 115 (35), 10570-10570, 2011 | 3 | 2011 |
| ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES ASSOCIATED WITH P13K MODULATION ED ANDERSON, SD ARONOW, NA BOYLES, MK DAHLGREN, S FENG, ... WO Patent WO 2021/202,964, 2021 | 2* | 2021 |
| Characterization of Potent Paracaspase MALT1 Inhibitors for Hematological Malignancies W Yin, Z Nie, K Dingley, M Trzoss, G Krilov, N Marshall, S Feng, ... Blood 138 (Supplement 1), 1187-1187, 2021 | 1 | 2021 |
| Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders F Shulu, M Lawrenz, GUO Jiaye, G Krilov, A Placzek, Z Nie, L Trzoss, ... US Patent App. 18/273,879, 2024 | | 2024 |
| Cyclic compounds and methods of using same F Shulu, M Lawrenz, G Krilov, A Placzek, Z Nie, L Trzoss, M Trzoss, ... US Patent App. 17/787,835, 2024 | | 2024 |
| SGR-1505 is a potent MALT1 protease inhibitor with a potential best-in-class profile W Yin, M Ye, N Marshall, JBL Tan, E Paull, Z Nie, MI Trzoss, G Krilov, ... Blood 142, 2997, 2023 | | 2023 |
| Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease ED Anderson, SD Aronow, NA Boyles, MK Dahlgren, F Shulu, ... US Patent App. 18/302,573, 2023 | | 2023 |
| CYCLIC COMPOUNDS AND METHODS OF USING SAME S FENG, M LAWRENZ, G KRILOV, A PLACZEK, Z NIE, L TRZOSS, ... WO Patent WO 2021/134,004, 2021 | | 2021 |
| Discovery of potent hits and solving ADME challenges with free energy perturbation and deep learning S Mondal, J Greenwood, S Feng, P Ghanakota, S Rafi, B Kim, Y Deng, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Prediction of Cytochrome P450-Mediated Metabolism Using a Combination of QSAR Derived Reactivity and Induced Fit Docking S Feng, RA Friesner arXiv, 1811.09366 [q-bio.BM], 2018 | | 2018 |
| Models of Heterogenous Actin Filaments J Fan, S Feng, M Saunders, L Lu, G Voth Biophysical Journal 102 (3), 372a, 2012 | | 2012 |
